JEAN BLANCHARD: Open Payments
NPI 1588005003 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 40 payments from 11 companies in 2025. Trend: 2023 $645 · 2024 $1,072 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $224 |
| Medtronic, Inc. | 2 | $143 |
| PFIZER INC. | 5 | $99 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $82 |
| Novo Nordisk Inc | 3 | $58 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Lilly USA, LLC | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
Products named: LEQVIO, SELECTSECURE, LifeVest, Wegovy, ELIQUIS, CAMZYOS, VYNDAQEL, VERQUVO.
Industry payments across LA — which companies pay providers there.
